Why it may matterVerify against the original reporting
Inflation restatement (IAS 29) adds a layer of earnings distortion, complicating comps and potentially pressuring the stock on a per-share basis. The quarter showed a widening net loss and margin compression, which historically weighs on near-term equity performance. While GMV and 3P revenue offer some positives, the combination of higher opex, weak EBITDA margin, and a major shareholder change risk (Kaspi) could sustain negative sentiment until profitability improves.
AI summary
What happened, with direct paths to the underlying reporting
HEPS reported Q2 2026 results restated under IAS 29 inflation accounting, highlighting inflation-adjusted metrics. Revenue rose 3.1% to 22.81B TRY with GMV of 56.7B TRY, but net loss widened to 1.89B TRY as opex rose. EBITDA was only 0.4% of GMV, while a fintech initiative contributed modest GMV; profitability remains challenged near term.
Hepsiburada restates Q2 2026 results under IAS 29 hyperinflation rules.
Q2 revenue up 3.1% to 22.81B TRY; GMV at 56.7B TRY.
Net loss for Q2 2026: 1.89B TRY; H1 net loss: 2.95B.
EBITDA margin shrank to 0.4% of GMV; H1 margin 0.6%.
Cash at 6/30: about 7.0B TRY; Q2 free cash flow: 1.55B TRY.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
